ABBOTT INDIA LIMITED
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents
Phase 3
Completed
- Conditions
- Bipolar I Disorder
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-07-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 227
- Registration Number
- NCT00195780
- Locations
- 🇺🇸
Kolin Research Group, Winter Park, Florida, United States
🇺🇸Clinco, Terre Haute, Indiana, United States
🇺🇸Rakesh Ranjan, M.D. & Associates, Inc., Lyndhurst, Ohio, United States
Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
Phase 3
Completed
- Conditions
- Bipolar I Disorder, Manic or Mixed
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-03-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 150
- Registration Number
- NCT00195767
- Locations
- 🇺🇸
Global Medical Information-Abbott, North Chicago, Illinois, United States
The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
Phase 3
Completed
- Conditions
- Migraine
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-02-08
- Lead Sponsor
- Abbott
- Target Recruit Count
- 300
- Registration Number
- NCT00195741
- Locations
- 🇺🇸
Global Medical Information - Abbott, North Chicago, Illinois, United States
Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis
Phase 3
Completed
- Conditions
- Psoriatic Arthritis
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-08-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 400
- Registration Number
- NCT00195689
- Locations
- 🇺🇸
Global Medical Information-Abbott Laboratories, Abbott Park, Illinois, United States
Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine
Phase 3
Completed
- Conditions
- Migraine
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-09-03
- Lead Sponsor
- Abbott
- Target Recruit Count
- 315
- Registration Number
- NCT00195806
- Locations
- 🇺🇸
Global Medical Information - Abbott, North Chicago, Illinois, United States
A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
Phase 3
Completed
- Conditions
- Migraines
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-07-31
- Lead Sponsor
- Abbott
- Target Recruit Count
- 114
- Registration Number
- NCT00195754
- Locations
- 🇺🇸
Global Medical Information - Abbott, North Chicago, Illinois, United States
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 129
- Registration Number
- NCT00160459
A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 73
- Registration Number
- NCT00160420
Safety of Treatment of Uterine Fibroids With Asoprisnil
Phase 3
Completed
- Conditions
- Fibroid UterusLeiomyomaMenorrhagiaMetrorrhagiaUterine Fibroids
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 166
- Registration Number
- NCT00156208
A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 130
- Registration Number
- NCT00160446
© Copyright 2025. All Rights Reserved by MedPath